Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.80 -0.14 (-2.09%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Exchange Rate Effect (2021 - 2026)

Ginkgo Bioworks Holdings' (DNA) quarterly Exchange Rate Effect came in at $43000.0 in Q2 2026, down 76.88% on a YoY basis from $186000.0 in Q2 2025, and up 133.33% quarter-over-quarter from -$129000.0 in Q1 2026.

Analysis

Ginkgo Bioworks Holdings (DNA) Exchange Rate Effect (2021 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings (DNA) has reported Exchange Rate Effect for 6 consecutive years, with $43000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Exchange Rate Effect fell 76.88% year-over-year to $43000.0; the trailing twelve-month figure through Jun 2026 stood at -$145000.0 (down 195.39% YoY), and the FY2025 full-year result was $201000.0, up 171.53% from the prior year.
  • Exchange Rate Effect grew to $43000.0 in Q2 2026 per DNA's latest filing, from -$129000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2022 and bottomed at -$469000.0 in Q2 2023.
  • Historically, Exchange Rate Effect has averaged $8555.6 across 5 years, with a median of -$30500.0 in 2023.
  • The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect soared 10090.91% in 2022, then plunged 503.85% in 2024.
  • Over 5 years, Exchange Rate Effect stood at $1.1 million in 2022, then tumbled by 90.72% to $102000.0 in 2023, then slumped by 171.57% to -$73000.0 in 2024, then tumbled by 108.22% to -$152000.0 in 2025, then surged by 128.29% to $43000.0 in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods registered $43000.0, -$129000.0, and -$152000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn -1.00 Mn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 221,000.00
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn -781,000.00
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn -1.60 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn -800,000.00
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn 43,000.00
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn -
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -21,155.67
10 VivoSim Labs 1.47 Mn 1.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43,000.00
Mar 31, 2026 -129,000.00
Dec 31, 2025 -152,000.00
Sep 30, 2025 93,000.00
Jun 30, 2025 186,000.00
Mar 31, 2025 74,000.00
Dec 31, 2024 -73,000.00
Sep 30, 2024 -35,000.00
Jun 30, 2024 -16,000.00
Mar 31, 2024 -157,000.00
Dec 31, 2023 102,000.00
Sep 30, 2023 -195,000.00
Jun 30, 2023 -469,000.00
Mar 31, 2023 -26,000.00
Dec 31, 2022 1.10 Mn
Sep 30, 2022 -87,000.00
Jun 30, 2022 -96,000.00
Mar 31, 2022 -8,000.00
Dec 31, 2021 -11,000.00
Sep 30, 2021 -877,000.00